HF
XBIT icon

HRT Financial’s XBiotech XBIT Stock Holding History

HRT Financial’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-26,156
Closed -$69K – 4163
2025
Q3 		$69K Buy
+26,156
New +$77.5K ﹤0.01% 2564
2024
Q2 		– Sell
-33,593
Closed -$273K – 3225
2024
Q1 		$273K Buy
+33,593
New +$193K ﹤0.01% 1612
2023
Q1 		– Sell
-13,279
Closed -$46K – 3286
2022
Q4 		$46K Sell
13,279
-27,708
-68% -$94.5K ﹤0.01% 2121
2022
Q3 		$148K Sell
40,987
-19,215
-32% -$90.4K ﹤0.01% 2292
2022
Q2 		$338K Buy
60,202
+29,981
+99% +$202K ﹤0.01% 1942
2022
Q1 		$261K Sell
30,221
-13,604
-31% -$136K ﹤0.01% 2331
2021
Q4 		$487K Buy
43,825
+7,981
+22% +$104K ﹤0.01% 1910
2021
Q3 		$464K Buy
+35,844
New +$571K ﹤0.01% 2064

Other funds holding XBIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HRT Financial's XBIT Position: Q4 2025 in Review

HRT Financial sold out of XBiotech (XBIT) in Q4 2025, closing a stake of 26,156 shares — an estimated $69K sold.

HRT Financial first reported a position in XBIT in Q3 2021 and held it in 8 quarters. The position peaked at $487K in Q4 2021. 41 funds tracked by Wall St. Rank hold XBIT as of Q4 2025.

  • HRT Financial reported no remaining XBiotech position as of Q4 2025 after selling out during the quarter.
  • HRT Financial sold 26,156 XBiotech shares in Q4 2025, an estimated $69K.
  • HRT Financial first reported a position in XBiotech in Q3 2021 and held it in 8 quarters.
  • HRT Financial's XBiotech position peaked at $487K in Q4 2021.
  • 41 funds tracked by Wall St. Rank held XBiotech as of Q4 2025.

Based on HRT Financial's 13F filing for Q4 2025, filed 12 Feb 2026.